Ruben Van Dijck

7PUBLICATIONS
22CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersRegenerative medicine (incl. stem cells)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 24, 2026
A critical view of the BJH publication on the lack of benefit of second-line daratumumab in patients with functional high-risk multiple myeloma.

|May 29, 2025
Clinical Benefit of Early Daratumumab Use in Multiple Myeloma is Undefined.

Ruben Van Dijck, Zoran Erjavec, John-John B Schnog

|Mar 27, 2025
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis.

Juan Carlos Hernández-Boluda, Adrián Mosquera-Orgueira, Luuk Gras

|Apr 12, 2023
Luspatercept as Potential Treatment for Congenital Sideroblastic Anemia.

Ruben Van Dijck, Alice M Goncalves Silva, Anita W Rijneveld

|Jul 06, 2021
COVID-19-associated pseudothrombocytopenia.

Ruben Van Dijck, Mandy N Lauw, Maurice Swinkels

|Apr 30, 2021
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma.

Ruben Van Dijck, Jeanette K Doorduijn, Jacoline E C Bromberg

Pageof 2

Frequent Collaborators

2 joint publications

John-John B Schnog

1 joint publications

A J Gerard Jansen

1 joint publications

Juan Carlos Hernandez-Boluda

1 joint publications

Adrian Mosquera Orgueira